Exagen Inc. XGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $72.16M.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s market capitalization?
- Exagen Inc. (XGN) reported market capitalization of $72.16M in Q1 2026.
- How has Exagen Inc.'s market capitalization changed year-over-year?
- Exagen Inc.'s market capitalization increased by 12.3% year-over-year, from $64.25M to $72.16M.
- What is the long-term trend for Exagen Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Exagen Inc.'s market capitalization has grown at a -8.4% compound annual growth rate (CAGR), from $213.37M to $137.79M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.